Beranda › Kanker Payudara › Minnesota › Saint Cloud
Uji klinis Kanker Payudara di Saint Cloud, MN
4 studi untuk Kanker Payudara mencari peserta di lokasi sekitar Saint Cloud (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Menerima pesertaFase 3
- Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Menerima pesertaFase 3
- Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Menerima pesertaStudi observasional
- Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud
Uji klinis Kanker Payudara di kota lain
- New York City, NY134 studi
- Houston, TX126 studi
- Boston, MA111 studi
- Nashville, TN80 studi
- Los Angeles, CA72 studi
- Edison, NJ68 studi
- St. Louis, MO64 studi
- Durham, NC63 studi
- Queens, NY63 studi
- Chicago, IL58 studi
- Philadelphia, PA56 studi
- Dallas, TX55 studi
Studi lain di Saint Cloud
- Kanker Prostat6 studi
- Gagal Jantung4 studi
- Penyakit Kardiovaskular4 studi
- Kanker Paru Non-Sel Kecil3 studi
- Kanker Paru3 studi
- Ambliopia3 studi
- Stenosis Katup Aorta3 studi
- Penyakit Arteri Koroner3 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.